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Background: Coronary artery calcifications (CAC) are markers of coronary atherosclerosis, but do not correlate well
with stenosis severity. This study intended to evaluate clinical situations where a combined approach of coronary
calcium scoring (CS) and nuclear stress test (SPECT-MPI) is useful for the detection of relevant CAD.
Methods: Patients with clinical indication for invasive coronary angiography (ICA) were included into our study
during 08/2005-09/2008. At first all patients underwent CS procedure as part of the study protocol performed by
either using a multidetector computed tomography (CT) scanner or a dual-source CT imager. CAC were
automatically defined by dedicated software and the Agatston score was semi-automatically calculated. A stress-rest
SPECT-MPI study was performed afterwards and scintigraphic images were evaluated quantitatively. Then all
patients underwent ICA. Thereby significant CAD was defined as luminal stenosis ≥75% in quantitative coronary
analysis (QCA) in ≥1 epicardial vessel. To compare data lacking Gaussian distribution an unpaired Wilcoxon-Test
(Mann–Whitney) was used. Otherwise a Students t-test for unpaired samples was applied. Calculations were
considered to be significant at a p-value of <0.05.
Results: We consecutively included 351 symptomatic patients (mean age: 61.2±12.3 years; range: 18–94 years; male:
n=240) with a mean Agatston score of 258.5±512.2 (range: 0–4214). ICA verified exclusion of significant CAD in
66/67 (98.5%) patients without CAC. CAC was detected in remaining 284 patients. In 132/284 patients (46.5%) with
CS>0 significant CAD was confirmed by ICA, and excluded in 152/284 (53.5%) patients. Sensitivity for CAD detection
by CS alone was calculated as 99.2%, specificity was 30.3%, and negative predictive value was 98.5%. An additional
SPECT in patients with CS>0 increased specificity to 80.9% while reducing sensitivity to 87.9%. Diagnostic accuracy
was 84.2%.
Conclusions: In patients without CS=0 significant CAD can be excluded with a high negative predictive value by
CS alone. An additional SPECT-MPI in those patients with CS>0 leads to a high diagnostic accuracy for the
detection of CAD while reducing the number of patients needing invasive diagnostic procedure.
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Table 1 Baseline characteristics of all 351 individuals
included in the study
All patients Male patients Female patients
351 (100.0%) 240 (68.4%) 111 (31.6%)
Mean age (years) 61.2 ± 12.3 60.0 ± 12.2 63.7 ± 12.2
Hypertension 236 (67.2%) 150 (62.5%) 86 (77.5%)
Family history 118 (33.6%) 85 (35.4%) 33 (29.7%)
Smoking 115 (32.8%) 88 (36.7%) 27 (18.9%)
Hyperlipidemia 196 (55.8%) 144 (60.0%) 52 (46.9%)
Adipositas 26 (7.4%) 13 (5.4%) 13 (11.7%)
Diabetes 38 (10.8%) 22 (9.2%) 16 (14.4%)
Average no. of
risk factors
2.4 ± 0.9 2.5 ± 1.1 2.3 ± 1.0
Mean CCS Score 2.4 ± 0.9 2.4 ± 0.7 2.4 ± 0.8
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Coronary artery calcifications (CAC) are a highly specific
marker of coronary atherosclerosis, the extent of which
is directly related to the atherosclerotic plaque burden
[1]. According to a large number of clinical studies CAC
is a reliable non-invasive diagnostic tool for the predic-
tion of subsequent cardiovascular events in populations
with elevated conventional risk factors [2-13]. In a large
observational report 10-year survival in asymptomatic
patients with CAD was 99.4% in patients with a CAC
score of 0 but was only 87.8% in those with a CAC score
of greater than 1000 [14]. According to current guide-
lines in symptomatic patients calcium scoring (CS)
might additionally serve as a useful filter prior to inva-
sive coronary angiography or stress nuclear imaging due
to its high sensitivity for flow-limiting CAD [15]. CAC
studies including over 7,600 symptomatic patients dem-
onstrate negative predictive values ranging from 96%
to 100%, allowing for a high level of confidence that
an individual in which CAC can be excluded has no
obstructive disease [11,12,16]. However, specificity and
diagnostic accuracy for prediction of flow-limiting steno-
sis in these patients is rather low [11-13]. Therefore, we
hypothesize that combining the results of CS with the
findings of a generally accepted functional imaging mo-
dality (such as single photon emission computed tom-
ography [SPECT] or positron emission tomography
[PET] myocardial perfusion imaging [MPI]) may en-
hance the prognostic value of both, resulting in benefits
for patient screening and for the diagnosis and treat-
ment of patients suspicious of having CAD [17-20].
Thus, the aim of our study was to evaluate different
clinical scenarios in a research setting in which CS pro-
cedure alone or in combination with SPECT-MPI may
enhance the diagnostic value of those non-invasive im-
aging modalities for the assessment of hemodynamically
relevant CAD as detected by conventional invasive cor-
onary angiography (ICA) in these particular patients.
Methods
Patients
An overall of 351 patients (mean age: 61.2±12.3 years;
range: 18–94 years; 240 male patients; 111 female
patients) were consecutively included into our study
during 08/2005-09/2008. All patients had a clinical in-
dication for ICA due to either non conclusive stress
test before (i.e. stress echocardiography or stress elec-
trocardiogram) or typical stable angina with Class II
angina pectoris symptoms at minimum according to the
Canadian Cardiovascular Society Classification (CCSC)
system [21]. Exclusion criteria were: (1) acute coronary
syndrome including ST-elevation myocardial infarction,
non-ST elevation myocardial infarction, or unstable an-
gina; (2) positive Troponin in blood testing; (3) unstableclinical conditions; (4) known coronary artery disease
after stent implantation procedure or coronary artery
bypass surgery; (5) age <18 years; (6) current pregnancy.
The study was conducted at the University of Munich,
Department of Cardiology, Campus Grosshadern, Mun-
ich, Germany and all patients gave written informed
consent to participate. The study protocol was approved
by the institutional review board and was in compliance
with the Declaration of Helsinki. Table 1 gives a
detailed overview of age and risk factors of all included
patients. Patients were symptomatic with a mean CCSC
of 2.4. Evaluation of cardiovascular risk profile revealed
a moderate to high pre-test probability of CAD with an
average number of 2.4 conventional cardiovascular risk
factors.
Coronary calcium scoring
CS procedure was performed by either using a multide-
tector CT scanner (Sensation 64; Siemens; Forchheim;
Germany) or a dual-source CT imager (Definition;
Siemens; Forchheim; Germany) in the thin-section
mode. Standardized acquisition protocol for both scan-
ner types included a tube voltage of 120 kV at a
current of 80 mAs. Rotation time was 0.33 s. Detector
collimation was 64x0.6 mm. Acquired images were
reconstructed using a B35f Kernel, reconstruction in-
crement was 1.5 mm resulting in a 50% overlap. Elec-
trocardiographically triggered images were acquired at
80% of the R-R interval during one end-inspiratory
breath-hold period. All images were electronically
transferred to one dedicated workstation for CS eval-
uation (Leonardo; Siemens; Forchheim; Germany).
Thereby, CAC were automatically defined as lesions with
attenuations greater than 130 Hounsfield Units in more
than four adjacent pixels. For quantification of CAC, the
Agatston score was calculated as the product of the
lesion's surface area and a weighting factor ranging from
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attenuation of the lesion [22]. All CS scans were evalu-
ated by a physician unaware of the patients' clinical
diagnoses.
SPECT Myocardial Perfusion Imaging
A 1-day technetium 99 m methoxyisobutyl-isonitrile
(Cardiolite; Bristol-Myers Squibb Medical Imaging;
North Billerica; Massachusetts) stress-rest SPECT MPI
protocol was used for all patients, as described previ-
ously [23]. Whenever possible patients were stressed
ergometrically on a stationary bicycle; otherwise a
pharmacological stress examination protocol was used.
Thereby bodyweight- adjusted 0.56 mg dipyramidole/kg
for an overall of 4 minutes was administered. No attenu-
ation correction or gated SPECT acquisition was per-
formed. Scintigraphic stress and rest images were
evaluated quantitatively by using a dedicated software
(AutoQUANT 6.0; Philips Medical Systems; Cleveland;
Ohio) [24-26] that employs a 20-segment left ventricular
model with a common five-point scoring system (0=
“normal perfusion”; 5= “no perfusion”) [22,27]. Results
were interpreted by two investigators blinded to CS and
ICA results. The summed stress scores (SSS) and
summed rest scores (SRS) of all segments were deter-
mined. The summed difference score (SDS) was calcu-
lated as the difference between the SSS and the SRS. A
SDS≥4 was defined as stress-induced ischemia and
counted as pathological SPECT-MPI.
Conventional invasive coronary angiography
ICA was performed by the Judkins approach according
to a standardized protocol using a 6-F catheter. Exami-
nations were blinded to the results of CS as well as
SPECT-MPI. Significant CAD was defined as luminal
stenosis ≥75% in quantitative coronary analysis (QCA)
in ≥1 epicardial vessel. For QCA the Quantcor QCA
software package (Quantcor QCA; CAAS II; V 5.0; Pie
Medical Imaging; Maastricht; Netherlands) was used.
The decision for coronary intervention (either stent im-
plantation procedure or coronary artery bypass surgery)
was independently made by the examiner, who was
blinded to the CS and SPECT-MPI results.
Statistical analysis
All statistical analyses were performed using the Sigma-
Stat software package (SigmaStat for Windows; V 3.10;
Systat Software GmbH; Erkrath; Germany). To com-
pare data lacking Gaussian distribution an unpaired
Wilcoxon-Test (Mann–Whitney) was used. Otherwise
a Students t-test for unpaired samples was applied. To
compare the diagnostic power of CS alone or in com-
bination with SPECT-MPI a ROC analysis was per-
formed. All numbers are given in mean ± standarddeviation. Calculations were considered to be signifi-
cant at a p-value of <0.05.
Results
Coronary calcium scoring
CS procedure was performed without any complication
in all patients with diagnostic image quality. Thus, none
of the patients had to be excluded from further analysis.
Mean coronary calcium Agatston score was 258.5±512.2
(range: 0–4213.7). In an overall of 67 patients (38 male;
29 female) coronary calcifications were excluded. In
the remaining 284 patients (202 male; 82 female) calci-
fied tissue was detected. Patients with CAC (mean age:
63.1±10.9 years; range: 31–94 years) were significantly
older than patients without calcified tissue (53.0±14.3 years;
range: 18–80 years; p<0.001). As expected, the Agatston
score increased with elevated patient age. Additionally, fe-
male patients showed lower overall CS values.
SPECT Myocardial Perfusion Imaging
All stress-rest SPECT-MPI examinations were per-
formed without complications. 230 (65.4%) patients were
stressed ergometrically on a stationary bicycle; and 121
(34.5%) patients, pharmacologically. In 303 (86.3%)
patients, 0.8 mg of nitroglycerine was administered sub-
lingually before injection of the radiopharmaceutical for
the rest image.
A stress induced myocardial ischemia was detected
in 148 patients (42.2%; 117 male; 31 female; mean age:
65.0±10.6 years; range: 35–94 years). In remaining
203 patients (57.8%; 123 male; 80 female) being sig-
nificantly younger (mean age: 58.4±12.7 years; range:
18–85 years; p<0.001) stress induced ischemia was
excluded.
Coronary artery disease detection
All invasive examinations were performed without any
complication. An overall of 133 patients (37.9%; mean
age 65.3±10.1 years; range: 37–94 years) had significant
CAD in ICA. This population consisted of 108 male
(mean age: 64.2±9.2 years; range: 43–94 years) and
25 female patients (mean age: 69.9±12.4 years; range:
37–86 years). A coronary 1-vessel disease was found in
64 cases (48.1%), 35 patients (26.3%) had a 2-vessel
disease, and all 3 coronary vessels were significantly
diseased in 34 patients (25.6%). Stent implantation
procedure was performed in 94 patients (70.7%) and
remaining 39 patients (29.3%) underwent bypass sur-
gery. Significant CAD was excluded by ICA in remaining
218 patients (62.1%; mean age: 58.7±12.8 years;
range: 18–87 years) being significantly younger
than patients with hemodynamically relevant CAD
(p<0.001).
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tions significant CAD leading to intervention was
excluded by ICA. Only one 65-year old female patient
had coronary 1-vessel disease leading to intervention in
left anterior coronary artery stenosis (drug-eluting stent
implantation procedure). 132/284 patients (46.5%) with
positive CS also showed significant disease in ICA.
Remaining 152 patients with detectable calcified tissue
had no significant CAD. Thus, we calculated a sensitivity
of 99.2%, a specificity of 30.3%, a negative predictive
value (NPV) of 98.5%, and a positive predictive value
(PPV) of 46.5% for calcium scoring alone with respect to
significant CAD detection. Diagnostic accuracy (DA)
was 56.4%. Table 2 gives a detailed overview over CS
results using different thresholds.
In an overall of 117/148 patients (79.1%) with myocar-
dial ischemia in SPECT-MPI (mean age: 65.0±10.6 years;
range: 35–95 years) significant CAD was confirmed by
ICA. False-positive results of SPECT-MPI were found in
remaining 31/148 patients (21.0%). In an overall of 187/
203 patients (92.2%) SPECT correctly excluded signifi-
cant CAD. False-negative results were found in
remaining 16/203 patients (7.9%). Thus, using SPECT
imaging as stand alone modality for significant CAD de-
tection revealed a sensitivity of 88%, a specificity of
85.8%, a NPV of 92.1%, and a PPV of 79.1%. DA for
SPECT-MPI was 86.6%. ROC analysis of SPECT-MPI
alone vs. SPECT-MPI in combination with CS revealed
no significant difference; 0.869 (95%-CI 0.829-0.902) vs.
0.870 (95%-CI 0.830-0.903) (p=0.902). Mean CS in
patients with ischemic myocardium in SPECT was sig-
nificantly higher than in patients without inducible is-
chemia (518.6±676.4 vs. 69.4±192.4; p<0.05).
In patients with calcified plaque tissue SPECT-MPI
detected stress induced ischemia in 145/284 patients
(51.1%). Of these patients, 116 (80.0%) suffered from sig-
nificant CAD as confirmed by ICA. In remaining 29
patients ICA excluded significant disease. In patients
without inducible ischemia in SPECT-MPI but with
positive CS (n=139) ICA confirmed exclusion of signifi-
cant CAD in 123/139 (88.5%). False negative results
were found in 16 patients (11.5%). Latter patients were
significantly older compared to the general patients
without detectable ischemia in our study populationTable 2 Diagnostic performance of CS using different
thresholds compared to SPECT-MPI
Sensitivity Specificity PPV NPV DA
CS =0 99.2% 30.3% 46.5% 98.5% 56.4%
CS <10 93.2% 52.8% 54.6% 92.7% 68.1%
CS <100 81.2% 83.5% 75.0% 87.9% 82.6%
CS <400 40.6% 95.4% 84.4% 72.5% 74.6%
SPECT-MPI 88.0% 85.8% 79.1% 92.1% 86.6%(mean age: 67.3±9.3 years vs. 58.4±12.7 years; p=0.0033),
and additionally showed a significantly higher overall
amount of calcified tissue (mean CS: 303.1±320.6 vs.
69.4±192.4; p<0.0001).
If coronary calcium scoring would have been used as a
kind of filter before SPECT imaging, disease prevalence
in this subgroup of patients with positive calcium scores
would increase to 46.5% (132/284). Utilizing this ap-
proach a sensitivity of 87.9% with a specificity of 80.9%
would have been calculated, and thus, NPV would be
88.5%, and PPV 80.0%. Theoretically, in 67 patients fur-
ther scanning procedure would have been avoided, with
one false negative result in aforementioned female pa-
tient. Adding additional 139 patients with positive CS,
but negative SPECT-MPI studies an overall of 206/351
(58.7%) patients would have been prevented from inva-
sive procedure with an overall of 17 (5.8%) false-negative
results.
Discussion
According to currently published reports only roughly
one third of all heart catheterizations performed are
leading to intervention [28]. To improve diagnostic yield
the current guidelines of international cardiology soci-
eties suggest non-invasive tests for the detection of CAD
in symptomatic patients, such as stress echocardiog-
raphy with reported pooled sensitivity of 80-85%, and
specificity of 85-86%, before invasive procedure [29].
Calcium scoring is a non-invasive modality which
detects coronary calcifications being a surrogate marker
for cardiac atherosclerosis. According to current litera-
ture the amount of calcified tissue correlates with the
risk of developing adverse cardiac events in the future,
such as myocardial infarction or sudden cardiac death.
In addition it seems that CS is a better risk predictor for
prospective cardiac events than currently available risk
stratification score systems, such as Framingham or
ATPIII risk score, in the way that CS reflects individual
atherosclerotic disease burden. Especially the exclusion
of coronary calcifications has been shown to exclude sig-
nificant CAD in symptomatic patients [11-13]. However,
the amount of calcium does not correlate well with sten-
osis severity [30]. Thus, aim of our study was to evaluate
the use of an approach combining CS determination and
SPECT-MPI. Especially we intended to identify the set-
tings in which one can refrain from additional imaging
or incremental information is won by the combination
of both modalities.
In our patient population of 351 consecutive patients
admitted for invasive coronary angiography, disease
prevalence of significant CAD needing intervention was
38% reflecting a typical population undergoing ICA. As
expected, specificity and positive predictive value of cor-
onary calcium scoring were rather low. Thus, detection
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sels utilizing this modality is not practicable. However, a
high sensitivity of 99.2%, and a high NPV of 98.5% sug-
gest CS being a useful tool for ruling out CAD by exclu-
sion of calcified plaque tissue. In these patients an
additional SPECT-MPI did not further increase diagnos-
tic accuracy as the negative predictive value of SPECT-
MPI is limited to 92.1%. Following these results we
would have correctly refrained from ICA and SPECT-
MPI in 66 patients (18.8%) of our study population. Al-
though there are some publications questioning the
safety of a zero to low coronary calcium scores for the
purpose of CAD exclusion in symptomatic patients, sev-
eral studies in large patient cohorts consistently have
shown a high NPV of >95% utilizing a threshold of zero
calcium similar to our study. But also in these studies
the safety of ruling out CAD is reduced by using higher
thresholds like a CS of 10 or a CS above the 25th age
and sex adjusted percentile instead of the exclusion of
calcified tissue [11-13]. The same was true for our study:
increasing CS thresholds would lead to an increase in
specificity and PPV. Concomitantly sensitivity and NPV
decreased to a value of 40.6% and 72.5%, respectively.
Thus CS would no longer be suitable as a filter for inva-
sive angiography and still not sufficient for the detection
of relevant stenosis with a PPV of 84.4%. Still, diagnostic
accuracy of CS at a threshold of 100 is comparable to
the diagnostic performance of SPECT-MPI.
Due to low specificities of positive coronary calcium
scores, a functional test like SPECT-MPI following initial
CS in case of calcified tissue detection is reasonable. In
our 284 patients with detectable coronary calcifications
51.1% (n=145) showed ischemia in SPECT-MPI followed
by intervention in 80.0% (n=116) of those patients. Spe-
cificity of this combined approach increased to 81% with
a disease prevalence of now 46.5%. Additionally a posi-
tive ischemic burden and its relation to a specific coron-
ary vessel territory, provides helpful information for
guiding interventional procedure.
In remaining 139 patients with positive calcium scores,
SPECT-MPI excluded significant CAD in 123 patients
(88.5%). Although CS did not help further with respect
to CAD detection in these particular patients, it none-
theless provides individual prognostic information and
estimates risk of developing prospective major coronary
events. In that respect CS might outperform SPECT-
MPI in symptomatic patients in the long-time follow-up
[31]. An overall of 16 patients (11.5%) were misclassified
by SPECT-MPI. Mean CS of these patients exceeded
300, with below 100 in only three cases, so that the ma-
jority of these patients presumably would have been put
on secondary prevention therapy due to the CS results
[32]. Furthermore it remains questionable whether these
patients in particular would benefit from additionalrevascularization according to the nuclear medicine sub-
study of the Clinical Outcomes Utilizing Revasculariza-
tion and Aggressive Drug Evaluation (COURAGE) trial
[33]. In this study Shaw et al. compared the effectiveness
of adding coronary revascularization in order to mini-
mize stress-induced ischemia with that of optimal med-
ical therapy, utilizing SPECT-MPI to find the end point.
They found that the outcome in patients with stable
CAD was most strongly associated with the amount of
residual ischemia after medical, or revascularization
therapy, or both.
Limitations
The utilization of different scanner technologies (MDCT
and DSCT scanners) poses the risk of inconsistent cal-
cium score values. According to a currently published
head-to-head comparison of these two scanner types by
Ghadri et al. revealed an excellent inter-scanner agree-
ment for Agatston scores with a correlation coefficient
of 0.976 despite relatively wide limits of agreement and a
coefficient of variation 15.1% even in case of different
vendors [34]. Calcium mass score as well as calcium vol-
ume score were also evaluated showing also excellent
correlation, but wider limits of agreement in Bland-
Altman Analysis. Interestingly the authors found that
the use of different workstations had a greater influence
on the comparability than the scanner technology. To
account for those possible sources of error a comparable
acquisition protocol for both scanner technologies rou-
tinely is used at our institution and the same worksta-
tion with the same software solution was utilized to
calculate the Agatston score. Indication for revasculari-
zation was solely based on detection of significant sten-
osis (≥75%) in QCA and was independently made by the
examiner without necessary verification of existing is-
chemia in order to guarantee for a blinded study design.
This approach to revascularization procedure represents
clinical practice at the time of study initiation. For com-
parison of SPECT-MPI a functional invasive measure-
ment such as fractional flow reserve (FFR) would have
been more appropriate, but FFR usually is not a widely
available diagnostic modality. The use of the ≥75%-
stenosis-degree criterion in order to define hemody-
namically relevant CAD theoretically results in a higher
number of false-positive findings with initially lower speci-
ficity and PPV. The likelihood of a ≥50%-stenosis causing
ischemia, which serves as CAD defining endpoint in the
majority of studies is relatively low and does not warrant
revascularization procedure in the majority of cases unless
prove of ischemic burden. Additionally selection bias must
be considered while interpreting the data presented. First
our evaluation was based on patients with clinical indica-
tion for ICA as referred by primary-care providers that do
not necessarily sent unselected chest-pain patients for
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single university site including only regional patients. Thus
our study population may not reflect general symptomatic
CAD patients.
Conclusions
It was the aim of the study to evaluate the diagnostic
accuracy of a combined approach using CS and SPECT-
MPI. In patients with a CS=0 an additional SPECT-MPI
did not lead to an increased diagnostic accuracy. The
exclusion of CAD was attained with a high NPV by
CS alone. In patients with a positive CS, SPECT-MPI
increased specificity and PPV for the detection of
CAD significantly.
In patients with a regular SPECT-MPI CS gave add-
itional information on patients’ coronary atherosclerosis
and cardiovascular risk.
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